Gastric Cancer

CLINICAL_TRIALS research · 2025-02-13

Clinical Trial Update: Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy [NA]

This update describes an ongoing clinical trial evaluating a geriatric intervention for frail patients with gastric, biliary tract (cholangi…

CLINICAL_TRIALS trial_result · 2025-02-12

Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 [Phase 1]

This Phase 1 study of CMG901 in patients with advanced solid tumors, including gastric cancer and pancreatic cancer, assesses safety, tolera…

CLINICAL_TRIALS research · 2025-02-12

Clinical Trial Update: Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

This clinical trial update reports epidemiological characteristics of gastric, gastroesophageal, and pancreatic cancers in Latin America; th…

CLINICAL_TRIALS trial_result · 2025-02-07

Clinical Trial Update: A Study of SGN-STNV in Advanced Solid Tumors [Phase 1]

Seagen's Phase 1 study of SGN-STNV in advanced solid tumors has been terminated.

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer [Phase 2]

A Phase 2 trial is evaluating first-line RC48 (disitamab vedotin) in combination with tislelizumab and S-1 for advanced gastric cancer.

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study

A retrospective real-world study evaluating retreatment with immune checkpoint inhibitors as second-line therapy for advanced gastric cancer…

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types [Phase 2, Phase 3]

A multicenter validation trial evaluating the PET imaging agent [18F]AlF-FAPI-74 to visualize cancer-associated fibroblasts across esophagea…

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]

Clinical trial update indicating an early-phase study of XNW27011 for multiple advanced solid tumors is currently recruiting.

CLINICAL_TRIALS trial_result · 2025-02-07

Clinical Trial Update: Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients [NA]

A completed clinical trial conducted in Chinese patients evaluating laparoscopic staging for locally advanced gastric cancer; no efficacy or…

CLINICAL_TRIALS withdrawal · 2025-02-07

Clinical Trial Update: Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers [Phase 1]

A Phase 1 neoadjuvant therapy trial for gastroesophageal junction and gastric cancers has been withdrawn.

CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Impact of Robotic Surgery on Systemic Immune-inflammation Index

A completed clinical trial evaluating whether robotic surgery influences the systemic immune-inflammation index in gastric cancer.

CLINICAL_TRIALS research · 2025-02-05

Clinical Trial Update: PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer [Phase 2]

A Phase 2 clinical trial evaluating JS001 in combination with neoadjuvant chemotherapy for gastric cancer and gastroesophageal junction canc…

CLINICAL_TRIALS research · 2025-01-31

Clinical Trial Update: Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE) [NA]

Clinical trial update for the AROMA 1 / BIORESOURCE study evaluating volatile biomarkers for oesophagogastric cancer, currently recruiting.

CLINICAL_TRIALS trial_result · 2025-01-29

Clinical Trial Update: Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers

This completed trial developed molecular classification models for early diagnosis of digestive system cancers and assessed their ability to…

CLINICAL_TRIALS research · 2025-01-29

Clinical Trial Update: A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

This clinical trial update describes a Phase 1/2 study of the bispecific antibody MCLA-158 in patients with advanced solid tumors. Recruitme…

CLINICAL_TRIALS research · 2025-01-28

Clinical Trial Update: Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

Viome's completed clinical trial update reports analyses of the intestinal microbiome, oral microbiome, and whole-blood transcriptome across…

FDA approval · 2025-01-27

FDA Approved: CYRAMZA — Supplemental Application (Eli Lilly and Company)

FDA approved a supplemental application for CYRAMZA (ramucirumab) from Eli Lilly and Company.